Comparison of the antihypertensive effect of a double dose of metoprolol versus the addition of hydrochlorothiazide to metoprolol
- PMID: 6363096
- DOI: 10.1007/BF00542342
Comparison of the antihypertensive effect of a double dose of metoprolol versus the addition of hydrochlorothiazide to metoprolol
Abstract
In 27 hypertensive patients whose blood pressure could not be adequately controlled with 200 mg metoprolol Durules alone, the effect of a double dose of metoprolol Durules (400 mg once daily) was compared with a fixed combination of 200 mg metoprolol and 25 mg hydrochlorothiazide (Selokomb). The study followed a double-blind cross-over schedule in 2 parallel groups. The reduction in diastolic blood pressure (p less than 0.01) was comparable in the two groups. A significant fall (p less than 0.01) in systolic blood pressure occurred with the metoprolol/hydrochlorothiazide combination. The subsequent change from the double dose of metoprolol Durules to the combination therapy also resulted in a fall in systolic blood pressure (p less than 0.05). Mean serum potassium and blood glucose levels did not change after each alteration in therapy. Most of the side-effects mentioned were mild and transient in character.
Similar articles
-
Antihypertensive treatment with metoprolol or hydrochlorothiazide in patients aged 60 to 75 years. Report from a double-blind international multicenter study.JAMA. 1986 Mar 14;255(10):1304-10. JAMA. 1986. PMID: 3511308 Clinical Trial.
-
Experiences with metoprolol Durules, a slow-release formulation in hypertension.J Int Med Res. 1980;8(1):44-9. doi: 10.1177/030006058000800108. J Int Med Res. 1980. PMID: 7358203
-
Efficacy and tolerability of a fixed combination of metoprolol CR/ZOK 100 mg and hydrochlorothiazide (HCT) 12.5 mg in comparison with the fixed combination of metoprolol and HCT.J Clin Pharmacol. 1990 Feb;30(S2):S78-81. doi: 10.1002/j.1552-4604.1990.tb03501.x. J Clin Pharmacol. 1990. PMID: 2179285 Clinical Trial. No abstract available.
-
A double-blind comparison of spironolactone and hydrochlorothiazide in hypertensive patients treated with metoprolol.Int J Clin Pharmacol Ther Toxicol. 1982 Jun;20(6):291-5. Int J Clin Pharmacol Ther Toxicol. 1982. PMID: 7049966 Clinical Trial.
-
Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.Am J Hypertens. 2006 Dec;19(12):1217-25. doi: 10.1016/j.amjhyper.2006.05.007. Am J Hypertens. 2006. PMID: 17161766 Clinical Trial.
Cited by
-
Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders.Drugs. 1986 May;31(5):376-429. doi: 10.2165/00003495-198631050-00002. Drugs. 1986. PMID: 2940080 Review.
-
Approaches to meeting the criteria for fixed dose antihypertensive combinations. Focus on metoprolol.Drugs. 1995 Sep;50(3):454-64. doi: 10.2165/00003495-199550030-00004. Drugs. 1995. PMID: 8521768 Review.
-
Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy.Pharmacoeconomics. 1994 Oct;6(4):370-400. doi: 10.2165/00019053-199406040-00004. Pharmacoeconomics. 1994. PMID: 10147474 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical